Aron M. Knickerbocker

2016

In 2016, Aron M. Knickerbocker earned a total compensation of $4.9M as Chief Operating Officer at Five Prime Therapeutics, a 58% increase compared to previous year.

Compensation breakdown

Bonus$155,700
Non-Equity Incentive Plan$215,000
Option Awards$3,182,872
Salary$418,333
Stock Awards$932,500
Other$6,000
Total$4,910,405

Knickerbocker received $3.2M in option awards, accounting for 65% of the total pay in 2016.

Knickerbocker also received $155.7K in bonus, $215K in non-equity incentive plan, $418.3K in salary, $932.5K in stock awards and $6K in other compensation.

Rankings

In 2016, Aron M. Knickerbocker's compensation ranked 1,652nd out of 14,075 executives tracked by ExecPay. In other words, Knickerbocker earned more than 88.3% of executives.

ClassificationRankingPercentile
All
1,652
out of 14,075
88th
Division
Manufacturing
555
out of 5,489
90th
Major group
Chemicals And Allied Products
156
out of 1,895
92nd
Industry group
Drugs
106
out of 1,538
93rd
Industry
Pharmaceutical Preparations
85
out of 1,176
93rd
Source: SEC filing on March 31, 2017.

Knickerbocker's colleagues

We found five more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2016.

2016

Lewis Williams

Five Prime Therapeutics

Chief Executive Officer

2016

Kevin Baker

Five Prime Therapeutics

Senior Vice President, Product Development

2016

Robert Sikorski

Five Prime Therapeutics

Chief Medical Officer

2016

Francis Sarena

Five Prime Therapeutics

Secretary

2016

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

In-depth

You may also like